T2 Biosystems, Inc. Marketable Securities (Non-Current)
T2 Biosystems, Inc. had Marketable Securities (Non-Current) of $10.00 million as of 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2022-03-23
- 2021-03-31: Marketable Securities, Noncurrent $10.00M.
- 2020-12-31: Marketable Securities, Noncurrent $10.00M.
- 2020-09-30: Marketable Securities, Noncurrent $20.19M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2021-03-31 | $10.00M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $10.00M 10-K · filed 2022-03-23 |
| 2020-09-30 | $20.19M 10-Q · filed 2020-11-05 |